Physician profile
Matthew Simonich
NPI 1790755056
$6,059.08
in general payments reported to CMS, 2019-2025
13 companies · $3,367 in 2025
The $3,367 reported for 2025 was more than what 78% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,189 · 2020: $14.85 · 2021: $1,238 · 2022: $14.36 · 2023: $33.15 · 2024: $203 · 2025: $3,367.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,046 · Food and Beverage: $1,556.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,046.17 |
| Food and Beverage | $1,556.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,506.96 | 2019-2025 | Mako, Blueprint Patient Specific Instrumentation, Osteoset |
| Arthrex, INC. | $1,250.25 | 2024-2025 | |
| Gemini Mountain Medical, LLC | $1,226.81 | 2021 | |
| Alliance Medical | $719.80 | 2024-2025 | |
| Depuy Synthes Sales INC. | $169.88 | 2019-2025 | Na, Dbx, Fibulink |
| Abbott Laboratories | $70.11 | 2019 | |
| Paragon 28, INC. | $24.65 | 2019 | |
| Ferring Pharmaceuticals INC. | $23.29 | 2019 | |
| Skeletal Dynamics INC | $14.85 | 2020 | |
| Fidia Pharma USA INC. | $14.36 | 2022 | |
| Bioventus LLC | $14.16 | 2019 | |
| Pacira Therapeutics, INC. | $12.72 | 2019 | |
| Sanofi-Aventis U.S. LLC | $11.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Simonich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.